CTNPT 031 — The HAVARTI trial
“Our study will test whether a licensed and commonly used medication could lead to a...
Learn MoreApril 10, 2018
CTNPT 029: Group Therapy for People Living with HAND
Approximately half of the aging HIV-positive population will be affected by HIV-Associated Neurocognitive Disorder (HAND)....
Learn More
In Memoriam: Dr. David Cooper
The CTN offers condolences to the family, friends, and colleagues of Dr. David Cooper. Dr....
Learn More
Trans Working Group Working To Remove Health Care Barriers
The Prevention and Vulnerable Populations (PVP) Core’s Trans Working Group has submitted their first...
Learn More
Canadian Guidelines on PrEP and nPEP Published
After nearly two years of work and consultation, the first Canadian Guidelines on pre-exposure prophylaxis...
Learn More
Why do we need PrEP Guidelines? Ask an expert. VIDEO
https://www.youtube.com/watch?v=iL21THt7Mxo&t=1s Despite efforts to reduce new incidences of HIV like condom campaigns, needle exchanges, and...
Learn More
Guest Blog: Dr. Nadine Kronfli on HCV treatment in Canadian prisons
Persons in custody in Canadian prisons have a 25-fold higher rate of hepatitis C (HCV)...
Learn More
Guest Blog: CTN Postdoc Dr. Malika Sharma
CTN Postdoctoral Fellow Dr. Malika Sharma writes about the current state of PrEP in Canada...
Learn More
Guest Blog: My Experience Interning at the CTN, Part 1
Hi everyone! My name is Sonia, and I’m one of the Communications and Knowledge Translation...
Learn More
Marina Klein’s tribute to Mark Wainberg at IAS 2017: VIDEO + TEXT
Read the full text of Dr. Klein’s speech below. Tribute to Mark Wainberg It’s with...
Learn More
Community Engagement Resource available online
A CTN Prevention and Vulnerable Populations Core working group has produced a resource for engaging...
Learn More